Emily Pimblett - Jun 18, 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ William Cowles, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Jun 18, 2024
Transactions value $
-$8,982
Form type
4
Date filed
6/21/2024, 02:57 PM
Previous filing
Mar 20, 2024
Next filing
Sep 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELYM Common Stock Options Exercise +5K 5K Jun 18, 2024 Direct F1
transaction ELYM Common Stock Sale -$8.98K -1.25K -24.9% $7.21 3.76K Jun 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Restricted Stock Units Options Exercise $0 -5K -12.5% $0.00 35K Jun 18, 2024 Common Stock 5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.